saroglitazar 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
dual peroxisome proliferator activated receptors-alpha and gamma(PPAR-alpha,gamma) agonists 5047 495399-09-2

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • saroglitazar
  • lipaglyn
  • ZYH1
  • saroglitazar magnesium
a PPARalpha and PPARgamma agonist
  • Molecular weight: 439.57
  • Formula: C25H29NO4S
  • CLOGP: 5.87
  • LIPINSKI: 1
  • HAC: 5
  • HDO: 1
  • TPSA: 60.69
  • ALOGS: -5.47
  • ROTB: 11

Drug dosage:

None

ADMET properties:

None

Approvals:

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

Drug Use | Suggest Off label Use Form| |View source of the data|




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

External reference:

Pharmaceutical products:

None

saroglitazar